Translational Session
Neonatal and Pediatric AKI: Advances in Prediction and Treatment
October 25, 2024 | 10:30 AM - 12:30 PM
Location: Room 33, Convention Center
Session Description
New tools are available for diagnosis, risk stratification, and treatment of AKI in both neonatal and pediatric patients. This session highlights how to translate findings from research studies and experimental therapies into clinical practice.
Learning Objective(s)
- Describe novel biomarkers and artificial intelligence to diagnosing AKI in pediatric patients
- Identify unique aspects of novel and targeted kidney replacement therapies in neonatal and pediatric patients
- Explain new approaches for identifying individuals at highest risk for AKI and CKD
Learning Pathway(s)
- Pediatric Nephrology
- AKI and Critical Care
Moderators
Presentations
- What's New for AKI Prediction in Neonates and Children: How to Implement Advances in Your Own Center
10:30 AM - 11:00 AM
- Precision Medicine Approaches to Identifying Children in the Intensive Care Unit with Risk for Future AKI and CKD
11:00 AM - 11:30 AM
- Artificial Intelligence Approaches to Increasing Recognition and Follow-Up of Pediatric AKI
11:30 AM - 12:00 PM
- Personalized Medicine Approaches in Choosing among New Neonatal Kidney Replacement Modalities
12:00 PM - 12:30 PM